Andra-Diana Cecan | Medicinal Plants | Research Excellence Award

Published on by Plant Scientist

Dr. Andra-Diana Cecan | Medicinal Plants | Research Excellence Award

Univeristy of Medicine and Pharmacy “Iuliu Hatieganu”, Cluj-Napoca | Romania

Dr. Andra-Diana Cecan is a physician and academic specializing in physiopathology and laboratory medicine. She earned her MD and PhD in Medicine from the University of Medicine and Pharmacy “Iuliu Hațieganu,” Cluj-Napoca, with doctoral research focused on the antitumoral potential of Mahonia aquifolium extracts. She currently serves as Șef de lucrări in Physiopathology and has extensive teaching experience across Romanian, English, and French programs. Her research interests include experimental oncology, inflammation, oxidative stress, metabolic disorders, and bioactive plant extracts. She has authored numerous ISI-indexed publications, reflecting recognized scientific contribution. Her work integrates education, research excellence, and translational biomedical impact.

                     Citation Metrics (Scopus)

200

150

100

50

10

0

 

Citations
101
Documents
8
h-index
6

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Elisa Buzzatti | Medicine | Research Excellence Award

Published on by Plant Scientist

Dr. Elisa Buzzatti | Medicine | Research Excellence Award

University Tor Vergata | Italy

Elisa Buzzatti is a physician–scientist and hematologist with advanced training in medical biotechnology and translational medicine. She earned her medical degree and specialization in Hematology at the University of Rome “Tor Vergata” and is currently enrolled in a doctoral program in Medical Biotechnology and Translational Medicine. Her clinical and research experience spans stem cell transplantation, acute and chronic leukemias, myeloproliferative disorders, and phase II–III clinical trials. She has contributed to numerous high-impact, peer-reviewed international publications and multicenter studies. Her research focuses on leukemia biology, immunotherapy, infectious complications, and measurable residual disease, aiming to improve precision and outcomes in hematologic malignancies.

                    Citation Metrics (Scopus)

400

300

200

100

10

0

 

Citations
241
Documents
35
h-index
10

Citations

Documents

h-index

View Scopus Profile   View Google Scholar Profile

Featured Publications

Shiva Vaheb Hosseinabadi | Genetics and Bioinformatics | Young Scientist Award

Published on by Plant Scientist

Ms. Shiva Vaheb Hosseinabadi | Genetics and Bioinformatics | Young Scientist Award

Zist Fanavari Novin biotechnology Institute | Iran

Dr. Shiva Vaheb Hosseinabadi is a molecular and cellular biologist and researcher currently serving as a molecular-techniques instructor and research supervisor at Zist Fanavari Novin Biotechnology Institute (since 2024). She earned her M.Sc. in Cellular and Molecular Sciences from Razi University (2019) and a B.Sc. in Molecular and Cellular Biology-Genetics from Islamic Azad University of Falavarjan. Her research and technical expertise span gene expression analysis, neurogenetics, cancer genomics, mutation analysis, next-generation sequencing (NGS), and bioinformatics. She has contributed to over a dozen peer-reviewed research articles — including studies on microRNA regulation in Parkinson’s disease models, co-frameshift mutations in acute myeloid leukemia, neurotoxicity attenuation via miR-361-5p, and exploration of lncRNA–miRNA networks in various cancers — with total publications exceeding 15 and cumulative citations in the low hundreds [exact citation count varies by database]. Dr. Hosseinabadi is proficient in molecular lab techniques (PCR/qPCR, cell culture, NGS), data analysis (R, Python, SPSS), and bioinformatics workflows. Her dual role as scientist and educator allows her to translate cutting-edge genetic research into practical training and application, contributing to advances in personalized medicine, neurogenetics, cancer biomarker discovery, and genomic diagnostics. Her ongoing work, including a 2025 book on cancer diagnostics and drug-resistance, underscores her commitment to bridging research and clinical translation.

Profile: Google Scholar

Featured Publications

Hosseinabadi, S. V., Tahamtan, H., Esfahani, M. M., Ghaedi-Heidari, R., Hashemi, M. S., Peymani, M., Sisakhtnezhad, S., Fahimi, H., & Ghaedi, K. (2025). Upregulation of miR-361-5p attenuates MPP+-induced neurotoxicity in dopaminergic SH-SY5Y cells as a Parkinson’s disease model. Journal of Biological Chemistry.

Roshani, H. R., Nasiri, A., Sattari, A., Rasaei, S., Karimian, P., Jannesari, F., … Hosseinabadi, S. V., & Azadeh, M. (2025). Uncovering an ADH1C–lncRNA regulatory axis linking alcohol metabolism to diagnostic potential in colorectal, breast, and gastric cancers.

Ghasroldasht, M. M., Hosseinabadi, S. V., Ebrahimi Askari, R., & Lotfalipour, R. (2025). Novel co-frameshift mutations in N- and C-terminal regions of CEBPA in acute myeloid leukemia: A case report. Cancer Genetics.

Esfahani, M. M., Mostashfi, M., Hosseinabadi, S. V., Hashemi, M. S., Peymani, M., & Nasr-Esfahani, M. H., et al. (2024). Unveiling the regulatory role of miR-101-3p on ZNF746 in a Parkinson’s disease cell model: Implications for therapeutic targeting. Neuroscience Research.

Mansoureh Azadeh | Genetics and Bioinformatics | Excellence in Research award

Published on by Plant Scientist

Prof. Dr. Mansoureh Azadeh | Genetics and Bioinformatics | Excellence in Research award

Zist Fanavari Novin Biotechnology Institute | Iran

Dr. Mansoureh Azadeh Jouneghani is a seasoned molecular and cellular biologist, currently CEO of PreventiGene — a startup she launched in 2023 to promote cancer prevention through advanced genetic testing. With a Ph.D. in Cellular and Molecular Biology, she also founded and leads Zist Fanavari Novin Biotechnology Institute since 2011, and has taught at the university level for 20 semesters at Azad University. Over her career she has led and managed substantial research initiatives in cancer genomics, drug-resistance mechanisms in cancer (especially breast cancer), genomic biomarkers for multiple sclerosis and cardiovascular disease, athlete genomics for performance and injury prevention, and personalized medicine. She is proficient in gene expression analysis, RNA sequencing, CRISPR, bioinformatics, and high-throughput data analytics, and has supervised training in numerous molecular-biology lab techniques (PCR, qRT-PCR, ELISA, cell culture, Western blot). Her research output includes over 100 publications, covering peer-reviewed articles, conference papers, and laboratory-technique handbooks; her work has contributed significantly to genomic medicine and translational biotechnology. As a leader and educator she bridges academia, industry, and clinical research — advancing personalized medicine, improving genomic diagnostics, and fostering vocational biotech education. Her dedication continues to contribute to better health outcomes, scientific innovation, and capacity-building in biotechnology.

Profile: Google Scholar

Featured Publications

Azadeh, M., Salehzadeh, A., Ghaedi, K., & Talesh Sasani, S. (2022). NEAT1 can be a diagnostic biomarker in breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: Integrated RNA targetome… Genes and Environment.

Fattahi Dolatabadi, N., Dehghani, A., Shahand, E., Yazdanshenas, M., et al. (2020). The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer.

Adami, B., Tabatabaeian, H., Ghaedi, K., Talebi, A., Azadeh, M., & Dehdashtian, E. (2019). miR-146a is deregulated in gastric cancer. Journal of Cancer Research and Therapeutics.

Assad Samani, L., Javadirad, S. M., Parsafar, S., Tabatabaeian, H., Ghaedi, K., et al. (2019). TP53 rs1625895 is related to breast cancer incidence and early death in Iranian population. Indian Journal of Clinical Biochemistry.

Dehghan, Z., Sadeghi, S., Tabatabaeian, H., Ghaedi, K., Azadeh, M., Fazilati, M., et al. (2017). *ESR1 single nucleotide polymorphism rs1062577 (c.3804T>A) alters the susceptibility of breast cancer risk in Iranian population. Gene.

Atef Samy | Plant Microbiology | Best Paper Award

Published on by Plant Scientist

Dr. Atef Samy | Plant Microbiology | Best Paper Award

Masr | Egypt

Dr. Atef El-Gebaly, PhD in Microbiology from Al-Azhar University (2025), is an accomplished researcher and academic with expertise in medical microbiology, virology, nanotechnology applications, and infection control. He has contributed significantly to the fields of microbial diagnostics and antiviral therapeutics, with an h-index of 4, more than 4 published documents, and over 45 citations in peer-reviewed international journals. His career spans diverse roles, including Assistant Lecturer of Microbiology at Misr University for Science and Technology (2021–2024), Teaching Assistant at Badr Academy for Science and Technology (2017–2020), Medical Laboratory Specialist at Suad Kafafi University Hospital (2010–2021), and earlier research roles at the Egyptian Russian University and Dar Al Fouad Hospital. Dr. El-Gebaly’s research interests focus on the antiviral and antimicrobial activities of nanoparticles, green synthesis of nanomaterials, essential oils as bioactive agents, and the development of alternative strategies against resistant pathogens. He has authored impactful works published in journals such as Inorganic Chemistry Communications, Biocatalysis and Agricultural Biotechnology, and Egyptian Journal of Chemistry. His achievements include advancing laboratory curricula, supervising students, and applying innovative methods in clinical microbiology. Recognized for his scientific contributions, Dr. El-Gebaly continues to pursue excellence in microbiology and nanomedicine, aiming to promote sustainable solutions in healthcare and biomedical research.

Profile: Scopus

Featured Publications

“Antiviral potential of copper and titanium dioxide nanoparticles against H1N1, Adenovirus 40 and herpes simplex virus type-II”

“Combination of nanoparticles (NPs) and essential oils (EOs) as promising alternatives to non-effective antibacterial, antifungal and antiviral agents: A review”

“Green synthesis, characterization and medicinal uses of silver nanoparticles (Ag-NPs), copper nanoparticles (Cu-NPs) and zinc oxide nanoparticles (ZnO-NPs) and their mechanism of action: A review”

“Effective Antiviral Activity of Tea Tree and Lemon Essential Oils against Influenza A virus (H1N1), Herpes Simplex virus Type 2 and Adenovirus Type 40”

“Green synthesized silver and zinc oxide nanoparticles using Ficus carica leaf extract and their activity on human viruses”

“A Predictive and Comparative Study Via Viral and Biochemical Measurements for Responders and Non-Responders Egyptian Hepatitis C Patients to Daclatasvir Plus Sofosbuvir Therapy”